Teva Pharmaceutical is a leader in generic drugs, but these struggling makers of branded drugs may be a better choice.

Find the latest Merck & Company, Inc. MRK analyst stock forecast, price target, and recommendation trends with in-depth analysis from research reports.

Private jets owned by six of the largest U.S. drugmakers have touched down in Washington-area airports 127 times this year, ...

BridgeBio Oncology Therapeutics (BBOT) targets KRAS and PI3Ka malignancies with next-generation small molecule therapeutics, ...

The loss of domvanalimab is the latest in a string of high-profile failures recorded across the biopharma world for the TIGIT ...

Two leading medical stocks that appear reasonable at current levels are AbbVie ( ABBV 0.78%) and Merck ( MRK +0.31%). The former has actually beaten the market in 2025, while the latter is in the red ...

GSK’s depemokimab, a long-acting biologic that’s key in the British pharma’s growth plan, has won an endorsement from ...

Researchers led by investigators at Mass General Brigham have published valuable information about a rare but serious complication of anti-cancer immunotherapy, providing the first large-scale ...

Innovation is accelerating through bispecifics and dual payload strategies | Emerging ADC development approaches such as ...

Preoperative radiation improved T-cell infiltration among patients with hormone receptor-positive, HER2-negative breast ...